Day: May 14, 2021
CALGARY, Alberta, May 14, 2021 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company“), a leading developer of spectroscopy-based technology, is pleased to announce that further to its news releases dated April 12, 2021 and May 7, 2021, the Early Warrant Exercise Incentive Program (“EWEIP“) has been completed and that 5,213,612 Warrants (as defined and described below) were exercised at the price of $0.22 per Warrant for gross proceeds to the Company of $1,146,994.64.
In January of 2021, FluroTech closed, in two tranches, a non-brokered private placement of units (“Units“), for aggregate gross proceeds of $2,531,000. Each Unit comprised one common share in the capital of FluroTech (“Common Share“) and one Common Share purchase warrant...
Whole Earth Brands, Inc. Reports First Quarter 2021 Financial Results and Reiterates Full Year Guidance
Written by Customer Service on . Posted in Public Companies.
First Quarter Branded CPG Segment Revenue Growth of 103%, Reflecting Strategic Acquisitions of Swerve and Wholesome; Both Acquisitions are Fully Integrated
First Quarter Branded CPG Segment Proforma Organic Constant Currency Revenue Growth of 10%
CHICAGO, May 14, 2021 (GLOBE NEWSWIRE) — Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a global food company enabling healthier lifestyles by providing access to premium plant-based sweeteners, flavor enhancers and other foods through a diverse portfolio of trusted brands and delicious products, today announced its financial results for its first quarter ended March 31, 2021. The Company also reiterated fiscal year 2021 guidance.
Irwin D. Simon, Executive Chairman, stated, “Our expanded portfolio of brands continues to outpace the category growth rate and is...
SL Green Signs Kyndryl to 22,500 Square Foot Lease at One Vanderbilt
Written by Customer Service on . Posted in Public Companies.
New headquarters for future IBM spin-off brings the building to 81% leased
NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE:SLG), Manhattan’s largest office landlord, today announced that Kyndryl has signed a 22,531-square-foot, 9-year lease, covering a portion of the 15th floor at One Vanderbilt Avenue for its new global headquarters. One Vanderbilt, the recently opened skyline-defining tower in the heart of East Midtown, is now 81% leased and remains on target to reach 90% leased by the end of this year.
Kyndryl is the independent company that will be created following the separation of IBM’s Managed Infrastructure Services business, which is expected to occur by the end of 2021. Kyndryl designs, runs and manages the most modern, efficient and reliable technology infrastructure for the world’s most important...
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Public Companies.
Interim futility analysis from the Phase 3 DISRUPT study of exebacase evaluating treatment superiority is anticipated in H2 2021
BARDA contract award provides up to $86.8 million for exebacase development
Strong financial position with cash and investments of $87.2 million as of March 31, 2021
YONKERS, New York, May 14, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX) a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced financial results and business updates for the first quarter ended March 31, 2021.
“After an excellent first quarter of 2021, during which we received a considerable contract award from...
Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP
Written by Customer Service on . Posted in Public Companies.
While the Phase 2/3 XIRIUS study did not meet its primary endpoint, data indicated positive trends in several prespecified secondary endpoints, such as a clinically relevant measure of visual acuity
Biogen will communicate next steps for the program after analyzing the complete data set
Currently there are no approved treatments for X-linked retinitis pigmentosa (XLRP), a rare inherited retinal disease that ultimately leads to blindness in most people with the conditionCAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced topline results from the Phase 2/3 XIRIUS study of cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients with X-linked retinitis pigmentosa (XLRP). XLRP is a rare, inherited retinal disease that is associated with progressive...
Marathon Gold and Miawpukek First Nation Sign Memorandum of Understanding
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 14, 2021 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) and Miawpukek First Nation are pleased to announce that they have concluded a Memorandum of Understanding (the “MOU”) relating to the Environmental Assessment and development of the Valentine Gold Project located in central Newfoundland (the “Project”). The MOU was signed by Matt Manson, President and CEO of Marathon, and Miawpukek Chief Mi’sel Joe.
The MOU provides for a process of ongoing engagement and consultation between Marathon and Miawpukek. This will include, amongst other things, the completion of a Traditional Knowledge/Traditional Land and Resource Use Study, funding for a community-based Liaison Officer, and the commencement of negotiations towards a Socio-Economic Agreement.
Matt Manson, President and CEO of...
Solid Biosciences Provides First Quarter 2021 Business Update and Financial Results
Written by Customer Service on . Posted in Public Companies.
– Patients 7 and 8 dosed in IGNITE-DMD Phase I/II clinical trial under new clinical protocol and second-generation SGT-001 manufacturing process; patient 8 experienced a serious adverse event –
– Long-term biopsy data generated from the ongoing IGNITE DMD trial demonstrate durable microdystrophin expression as measured up to two years post dosing of SGT-001. Data to be presented today at ASGCT at 1:45 PM ET –
– Continued research and innovation in musculoskeletal therapy generates next-generation DMD gene transfer candidate, SGT-003 –
– Company ends Q1 with $268.5 million in cash; cash runway into Q4 2022 –
– Company to hold conference call at 8:30am ET today –
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company...
Knight Therapeutics Reports First Quarter 2021 Results
Written by Customer Service on . Posted in Public Companies.
MONTREAL, May 14, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.
Q1 2021 Highlights
FinancialsRevenues were $46,069, an increase of $230 or 1% over prior year.
Gross margin generated of $20,580 or 45% compared to $19,860 or 43% in prior year.
Adjusted EBITDA1 was $5,580, an increase of $2,383 or 75% over prior year.
Interest income generated of $1,998 a decrease of $2,651 or 57% over prior year.
Net income was $3,558 compared to net loss of $9,477 in prior year.
Cash inflow from operations was $17,207...
Arena Minerals Announces Closing of Pampa Paciencia Property Sale to Astra Exploration
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 14, 2021 (GLOBE NEWSWIRE) — Arena Minerals Inc. (“Arena” or the “Company”) (TSX-V: AN) is pleased to announce completion of the sale of the Pampa Paciencia epithermal gold property (the “Property”), located in the Atacama region of northern Chile, to Astra Exploration Ltd (“Astra”), a private mineral exploration company. In consideration for Arena’s 80% ownership of the Property the Company has received 5.82 million of shares of Astra, representing 40% of the issued and outstanding shares of Astra with a deemed value of $1.6 million.
Astra is a newly formed private mineral exploration company led by a proven management team with previous exploration success in discovering epithermal gold deposits. Astra intends to initiate a drill program on the Property and complete a going public transaction...
Extended Stay America Responds to Tarsadia and Highlights Compelling Reasons to Support the Transaction with Blackstone and Starwood Capital
Written by Customer Service on . Posted in Public Companies.
Image 1Image 1Image 2Image 2Image 3Image 3Image 4Image 4Image 5Image 5Image 6Image 6Image 7Image 7New Letter to Shareholders Provides Comprehensive Discussion of the Transaction Rationale and the Immediate, Certain and Compelling $19.50 Per Paired Share Cash Value
Addresses Tarsadia’s Misleading and Flawed Arguments
Urges Shareholders Vote “FOR” the Transaction on the WHITE Company Proxy Card in Vote Set for June 8, 2021
CHARLOTTE, N.C., May 14, 2021 (GLOBE NEWSWIRE) — Extended Stay America, Inc. (“ESA”) and its paired-share REIT, ESH Hospitality, Inc. (“ESH” and, together with ESA, “Extended Stay” or the “Company”) (NASDAQ: STAY) today sent a new letter to shareholders detailing the strategic and economic factors...